Dianthus Therapeutics Inc (DNTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 6,235 | 2,826 | 6,417 | 0 | 0 |
| Gross Profit | 6,235 | 2,826 | 6,417 | N/A | N/A |
| Operating Expenses | 108,099 | 51,000 | 36,122 | 74,692 | 78,702 |
| Operating Income | -101,864 | -48,174 | -29,705 | -74,692 | -78,702 |
| Other Income | 16,895 | 4,619 | 1,229 | 3,556 | 3,766 |
| Pre-tax Income | -84,969 | -43,555 | -28,476 | -71,136 | -74,936 |
| Net Income Continuous | -84,969 | -43,555 | -28,476 | -71,136 | -74,936 |
| Net Income | $-84,969 | $-43,555 | $-28,476 | $-71,136 | $-74,936 |
| EPS Basic Total Ops | -2.55 | -8.45 | -32.57 | -20.64 | -27.36 |
| EPS Basic Continuous Ops | -2.55 | -8.45 | -32.58 | -20.71 | -27.30 |
| EPS Diluted Total Ops | -2.55 | -8.45 | -32.57 | -20.64 | -27.36 |
| EPS Diluted Continuous Ops | -2.55 | -8.45 | -32.58 | -20.71 | -27.30 |
| EPS Diluted Before Non-Recurring Items | -2.55 | -8.45 | N/A | -20.64 | -27.36 |
| EBITDA(a) | $-107,470 | $-49,242 | $-30,164 | $-72,672 | $-76,724 |